• About
  • Advertise
  • Contact
  • Login
Newsletter
NRI Affairs
Youtube Channel
  • News
  • Video
  • Opinion
  • Culture
  • Visa
  • Student Hub
  • Business
  • Travel
  • Events
  • Other
No Result
View All Result
  • News
  • Video
  • Opinion
  • Culture
  • Visa
  • Student Hub
  • Business
  • Travel
  • Events
  • Other
No Result
View All Result
NRI Affairs
No Result
View All Result
Home News

India’s COVOVAX gets WHO approval for emergency use

NRI Affairs News Desk by NRI Affairs News Desk
December 20, 2021
in News
Reading Time: 2 mins read
A A
0
India’s COVOVAX gets WHO approval for emergency use

Image: Pixabay

Share on FacebookShare on Twitter
Advertisements

The World Health Organization has listed Covovax, produced by Serum Institute of India under the licence from Novavax, for emergency use.

The ninth Covid-19 vaccine approved for emergency use is part of the COVAX facility portfolio and will be boosting efforts in vaccinating people, especially in lower-income countries.

Approval after due assessment

Covovax was thoroughly assessed for its quality, safety, and efficacy of COVID-19 vaccines before being granted the Emergency Use Listing (EUL). CovovaxTM was assessed under the WHO EUL procedure based on the review of data on quality, safety, and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.

According to the Technical Advisory Group, the vaccine meets WHO standards for protection against COVID-19 and is fit for global use as its benefits outweigh any risks.

This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O. approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration, @Novavax @WHO @GaviSeth @Gavi @gatesfoundation https://t.co/7C8RVZa3Y4

— Adar Poonawalla (@adarpoonawalla) December 17, 2021

Vaccines: Best weapon

Advertisements

The listing of Covovax will strengthen the fight against Coronavirus. WHO Assistant-Director General for Access to Medicines and Health Products, Dr. Mariangela Simao said that even with new variants emerging, vaccines remain one of the most effective tools to protect people against serious illness and death from SARS-COV-2.

Further, the listing will increase vaccine access in lower-income countries. According to WHO, 41 of these countries have still not been able to vaccinate 10% of their populations, while 98 countries have not reached 40%.

About Covovax

Covovax, a subunit of the vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), requires two doses. The vaccine is produced by creating an engineered baculovirus containing a gene for a modified SARS-CoV-2 spike protein. It is stable at 2 to 8 °C refrigerated temperatures.

In addition to Covovax, India’s Covishield, developed by the Serum Institute of India was issued EUL on 15 February 2021, while Covaxin by Bharat Biotech was given a nod on 3 November 2021.

Logo2
NRI Affairs News Desk

NRI Affairs News Desk

NRI Affairs News Desk

Related Posts

Indian-Australian Community Stands in Solidarity: Sydney Vigil Honors Victims of Pahalgam Terror Attack
News

Indian-Australian Community Stands in Solidarity: Sydney Vigil Honors Victims of Pahalgam Terror Attack

April 30, 2025
Melbourne Honours Legacy of Indian Social Reformers with Cultural Celebration
News

Melbourne Honours Legacy of Indian Social Reformers with Cultural Celebration

April 27, 2025
Explained: Do NRIs Need to Disclose Foreign Bank Accounts in Their Indian Tax Returns?
News

Explained: Do NRIs Need to Disclose Foreign Bank Accounts in Their Indian Tax Returns?

April 25, 2025
Next Post
Modi

Modi Ji! Aurangzeb ruled through high caste Hindus; was cruel to Muslims too

‘India Out’: Campaign in Maldives against India

‘India Out’: Campaign in Maldives against India

Denied

'Caught delivering cash in transit': Indian family to be deported

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

27-year-old Tajinder Singh of Jacks Point

Indian-origin man, who had not visited his family in India for seven years, killed in a car crash

3 years ago
Elon Musk and Vivek Ramaswamy’s support for H-1B visas sparks debate among Trump supporters

Elon Musk and Vivek Ramaswamy’s support for H-1B visas sparks debate among Trump supporters

4 months ago
The Kashmir files

New Zealand to review release of The Kashmir Files; shows on hold until further notice

3 years ago
India set for G20 Presidency

India set for G20 Presidency

3 years ago

Categories

  • Business
  • Events
  • Literature
  • Multimedia
  • News
  • nriaffairs
  • Opinion
  • Other
  • People
  • Student Hub
  • Top Stories
  • Travel
  • Uncategorized
  • Visa

Topics

Air India Australia california Canada caste china COVID-19 cricket Europe Gaza Germany Green Card h1b visa Hindu immigration India india-australia Indian Indian-American Indian-origin indian diaspora indian origin indian student Indian Students Khalistan London Modi Narendra Modi New Zealand NRI NSW Pakistan Palestine Singapore student students travel trump UAE uk US USA us visa Victoria visa
NRI Affairs

© 2025 NRI Affairs.

Navigate Site

  • About
  • Advertise
  • Contact

Follow Us

No Result
View All Result
  • News
  • Video
  • Opinion
  • Culture
  • Visa
  • Student Hub
  • Business
  • Travel
  • Events
  • Other

© 2025 NRI Affairs.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
WP Twitter Auto Publish Powered By : XYZScripts.com